§ 21-28.10-1. Definitions.
Unless the context otherwise requires, the following terms shall be construed in this chapter to have the following meanings:
(1) “Distribute” means distribute as defined in § 21-28-1.02.
(2) “Distributor” means distributor as defined in § 21-28-1.02.
(3) “Executive office” means the executive office of health and human services.
(4) “Manufacture” means manufacture as defined in § 21-28-1.02.
(5) “Manufacturer” means manufacturer as defined in § 21-28-1.02.
(6) “Market share” means the total opioid stewardship fund amount measured as a percentage of each manufacturer’s, distributor’s and wholesaler’s gross, in-state opioid sales in dollars from the previous calendar year as reported to the U.S. Drug Enforcement Administration (DEA) on its Automation of Reports and Consolidated Orders System (ARCOS) report.
(7) “Secretary” means the secretary of the executive office of health and human services.
(8) “Wholesaler” means wholesaler as defined in § 21-28-1.02.
History of Section.P.L. 2019, ch. 88, art. 13, § 17; P.L. 2022, ch. 231, art. 3, § 8, effective June 27, 2022.
Structure Rhode Island General Laws
Chapter 21-28.10 - Opioid Stewardship Act
Section 21-28.10-1. - Definitions.
Section 21-28.10-3. - Determination of market share and registration fee.
Section 21-28.10-4. - Reports and records.
Section 21-28.10-5. - Payment of market share.
Section 21-28.10-6. - Rebate of market share.
Section 21-28.10-7. - Licensee opportunity to appeal.
Section 21-28.10-8. - Annual reporting.
Section 21-28.10-9. - Penalties.
Section 21-28.10-10. - Creation of opioid stewardship fund.
Section 21-28.10-11. - Allocation.
Section 21-28.10-12. - Severability.